Global Circulating Biomarker Market Insights and Forecast to 2028

Global Circulating Biomarker Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Circulating Biomarker Product Introduction
1.2 Market by Type
1.2.1 Global Circulating Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Circulating DNA
1.2.3 Circulating Tumor Cells
1.2.4 Other
1.3 Market by Application
1.3.1 Global Circulating Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Circulating Biomarker Sales Estimates and Forecasts 2017-2028
2.2 Global Circulating Biomarker Revenue Estimates and Forecasts 2017-2028
2.3 Global Circulating Biomarker Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Circulating Biomarker Sales by Region
2.4.1 Global Circulating Biomarker Sales by Region (2017-2022)
2.4.2 Global Sales Circulating Biomarker by Region (2023-2028)
2.5 Global Circulating Biomarker Revenue by Region
2.5.1 Global Circulating Biomarker Revenue by Region (2017-2022)
2.5.2 Global Circulating Biomarker Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Circulating Biomarker Sales by Manufacturers
3.1.1 Global Top Circulating Biomarker Manufacturers by Sales (2017-2022)
3.1.2 Global Circulating Biomarker Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Circulating Biomarker in 2021
3.2 Global Circulating Biomarker Revenue by Manufacturers
3.2.1 Global Circulating Biomarker Revenue by Manufacturers (2017-2022)
3.2.2 Global Circulating Biomarker Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Circulating Biomarker Revenue in 2021
3.3 Global Circulating Biomarker Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Circulating Biomarker Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Circulating Biomarker Sales by Type
4.1.1 Global Circulating Biomarker Historical Sales by Type (2017-2022)
4.1.2 Global Circulating Biomarker Forecasted Sales by Type (2023-2028)
4.1.3 Global Circulating Biomarker Sales Market Share by Type (2017-2028)
4.2 Global Circulating Biomarker Revenue by Type
4.2.1 Global Circulating Biomarker Historical Revenue by Type (2017-2022)
4.2.2 Global Circulating Biomarker Forecasted Revenue by Type (2023-2028)
4.2.3 Global Circulating Biomarker Revenue Market Share by Type (2017-2028)
4.3 Global Circulating Biomarker Price by Type
4.3.1 Global Circulating Biomarker Price by Type (2017-2022)
4.3.2 Global Circulating Biomarker Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Circulating Biomarker Sales by Application
5.1.1 Global Circulating Biomarker Historical Sales by Application (2017-2022)
5.1.2 Global Circulating Biomarker Forecasted Sales by Application (2023-2028)
5.1.3 Global Circulating Biomarker Sales Market Share by Application (2017-2028)
5.2 Global Circulating Biomarker Revenue by Application
5.2.1 Global Circulating Biomarker Historical Revenue by Application (2017-2022)
5.2.2 Global Circulating Biomarker Forecasted Revenue by Application (2023-2028)
5.2.3 Global Circulating Biomarker Revenue Market Share by Application (2017-2028)
5.3 Global Circulating Biomarker Price by Application
5.3.1 Global Circulating Biomarker Price by Application (2017-2022)
5.3.2 Global Circulating Biomarker Price Forecast by Application (2023-2028)
6 North America
6.1 North America Circulating Biomarker Market Size by Type
6.1.1 North America Circulating Biomarker Sales by Type (2017-2028)
6.1.2 North America Circulating Biomarker Revenue by Type (2017-2028)
6.2 North America Circulating Biomarker Market Size by Application
6.2.1 North America Circulating Biomarker Sales by Application (2017-2028)
6.2.2 North America Circulating Biomarker Revenue by Application (2017-2028)
6.3 North America Circulating Biomarker Market Size by Country
6.3.1 North America Circulating Biomarker Sales by Country (2017-2028)
6.3.2 North America Circulating Biomarker Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Circulating Biomarker Market Size by Type
7.1.1 Europe Circulating Biomarker Sales by Type (2017-2028)
7.1.2 Europe Circulating Biomarker Revenue by Type (2017-2028)
7.2 Europe Circulating Biomarker Market Size by Application
7.2.1 Europe Circulating Biomarker Sales by Application (2017-2028)
7.2.2 Europe Circulating Biomarker Revenue by Application (2017-2028)
7.3 Europe Circulating Biomarker Market Size by Country
7.3.1 Europe Circulating Biomarker Sales by Country (2017-2028)
7.3.2 Europe Circulating Biomarker Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Circulating Biomarker Market Size by Type
8.1.1 Asia Pacific Circulating Biomarker Sales by Type (2017-2028)
8.1.2 Asia Pacific Circulating Biomarker Revenue by Type (2017-2028)
8.2 Asia Pacific Circulating Biomarker Market Size by Application
8.2.1 Asia Pacific Circulating Biomarker Sales by Application (2017-2028)
8.2.2 Asia Pacific Circulating Biomarker Revenue by Application (2017-2028)
8.3 Asia Pacific Circulating Biomarker Market Size by Region
8.3.1 Asia Pacific Circulating Biomarker Sales by Region (2017-2028)
8.3.2 Asia Pacific Circulating Biomarker Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Circulating Biomarker Market Size by Type
9.1.1 Latin America Circulating Biomarker Sales by Type (2017-2028)
9.1.2 Latin America Circulating Biomarker Revenue by Type (2017-2028)
9.2 Latin America Circulating Biomarker Market Size by Application
9.2.1 Latin America Circulating Biomarker Sales by Application (2017-2028)
9.2.2 Latin America Circulating Biomarker Revenue by Application (2017-2028)
9.3 Latin America Circulating Biomarker Market Size by Country
9.3.1 Latin America Circulating Biomarker Sales by Country (2017-2028)
9.3.2 Latin America Circulating Biomarker Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Circulating Biomarker Market Size by Type
10.1.1 Middle East and Africa Circulating Biomarker Sales by Type (2017-2028)
10.1.2 Middle East and Africa Circulating Biomarker Revenue by Type (2017-2028)
10.2 Middle East and Africa Circulating Biomarker Market Size by Application
10.2.1 Middle East and Africa Circulating Biomarker Sales by Application (2017-2028)
10.2.2 Middle East and Africa Circulating Biomarker Revenue by Application (2017-2028)
10.3 Middle East and Africa Circulating Biomarker Market Size by Country
10.3.1 Middle East and Africa Circulating Biomarker Sales by Country (2017-2028)
10.3.2 Middle East and Africa Circulating Biomarker Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Corporation Information
11.2.2 Becton, Dickinson and Company Overview
11.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Becton, Dickinson and Company Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Becton, Dickinson and Company Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Corporation Information
11.3.2 GE Healthcare Overview
11.3.3 GE Healthcare Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GE Healthcare Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GE Healthcare Recent Developments
11.4 Epigenomics AG
11.4.1 Epigenomics AG Corporation Information
11.4.2 Epigenomics AG Overview
11.4.3 Epigenomics AG Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Epigenomics AG Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epigenomics AG Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Corporation Information
11.5.2 Agilent Technologies Overview
11.5.3 Agilent Technologies Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Agilent Technologies Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Agilent Technologies Recent Developments
11.6 Biocept
11.6.1 Biocept Corporation Information
11.6.2 Biocept Overview
11.6.3 Biocept Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biocept Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biocept Recent Developments
11.7 Affymetrix
11.7.1 Affymetrix Corporation Information
11.7.2 Affymetrix Overview
11.7.3 Affymetrix Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Affymetrix Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Affymetrix Recent Developments
11.8 Fluxion Biosciences
11.8.1 Fluxion Biosciences Corporation Information
11.8.2 Fluxion Biosciences Overview
11.8.3 Fluxion Biosciences Circulating Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Fluxion Biosciences Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fluxion Biosciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Circulating Biomarker Industry Chain Analysis
12.2 Circulating Biomarker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Circulating Biomarker Production Mode & Process
12.4 Circulating Biomarker Sales and Marketing
12.4.1 Circulating Biomarker Sales Channels
12.4.2 Circulating Biomarker Distributors
12.5 Circulating Biomarker Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Circulating Biomarker Industry Trends
13.2 Circulating Biomarker Market Drivers
13.3 Circulating Biomarker Market Challenges
13.4 Circulating Biomarker Market Restraints
14 Key Findings in The Global Circulating Biomarker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Circulating Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Circulating DNA
Table 3. Major Manufacturers of Circulating Tumor Cells
Table 4. Major Manufacturers of Other
Table 5. Global Circulating Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Circulating Biomarker Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Circulating Biomarker Sales by Region (2017-2022) & (K MT)
Table 8. Global Circulating Biomarker Sales Market Share by Region (2017-2022)
Table 9. Global Circulating Biomarker Sales by Region (2023-2028) & (K MT)
Table 10. Global Circulating Biomarker Sales Market Share by Region (2023-2028)
Table 11. Global Circulating Biomarker Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Circulating Biomarker Revenue Market Share by Region (2017-2022)
Table 13. Global Circulating Biomarker Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Circulating Biomarker Revenue Market Share by Region (2023-2028)
Table 15. Global Circulating Biomarker Sales by Manufacturers (2017-2022) & (K MT)
Table 16. Global Circulating Biomarker Sales Share by Manufacturers (2017-2022)
Table 17. Global Circulating Biomarker Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Circulating Biomarker Revenue Share by Manufacturers (2017-2022)
Table 19. Circulating Biomarker Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Circulating Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Circulating Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker as of 2021)
Table 22. Circulating Biomarker Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Circulating Biomarker Product Offered
Table 24. Date of Manufacturers Enter into Circulating Biomarker Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 27. Global Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 28. Global Circulating Biomarker Sales Share by Type (2017-2022)
Table 29. Global Circulating Biomarker Sales Share by Type (2023-2028)
Table 30. Global Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Circulating Biomarker Revenue Share by Type (2017-2022)
Table 33. Global Circulating Biomarker Revenue Share by Type (2023-2028)
Table 34. Circulating Biomarker Price by Type (2017-2022) & (USD/MT)
Table 35. Global Circulating Biomarker Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 37. Global Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 38. Global Circulating Biomarker Sales Share by Application (2017-2022)
Table 39. Global Circulating Biomarker Sales Share by Application (2023-2028)
Table 40. Global Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Circulating Biomarker Revenue Share by Application (2017-2022)
Table 43. Global Circulating Biomarker Revenue Share by Application (2023-2028)
Table 44. Circulating Biomarker Price by Application (2017-2022) & (USD/MT)
Table 45. Global Circulating Biomarker Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 47. North America Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 48. North America Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 51. North America Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 52. North America Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Circulating Biomarker Sales by Country (2017-2022) & (K MT)
Table 55. North America Circulating Biomarker Sales by Country (2023-2028) & (K MT)
Table 56. North America Circulating Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Circulating Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 59. Europe Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 60. Europe Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 63. Europe Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 64. Europe Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Circulating Biomarker Sales by Country (2017-2022) & (K MT)
Table 67. Europe Circulating Biomarker Sales by Country (2023-2028) & (K MT)
Table 68. Europe Circulating Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Circulating Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 71. Asia Pacific Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 72. Asia Pacific Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 75. Asia Pacific Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 76. Asia Pacific Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Circulating Biomarker Sales by Region (2017-2022) & (K MT)
Table 79. Asia Pacific Circulating Biomarker Sales by Region (2023-2028) & (K MT)
Table 80. Asia Pacific Circulating Biomarker Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Circulating Biomarker Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 83. Latin America Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 84. Latin America Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 87. Latin America Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 88. Latin America Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Circulating Biomarker Sales by Country (2017-2022) & (K MT)
Table 91. Latin America Circulating Biomarker Sales by Country (2023-2028) & (K MT)
Table 92. Latin America Circulating Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Circulating Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Circulating Biomarker Sales by Type (2017-2022) & (K MT)
Table 95. Middle East and Africa Circulating Biomarker Sales by Type (2023-2028) & (K MT)
Table 96. Middle East and Africa Circulating Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Circulating Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Circulating Biomarker Sales by Application (2017-2022) & (K MT)
Table 99. Middle East and Africa Circulating Biomarker Sales by Application (2023-2028) & (K MT)
Table 100. Middle East and Africa Circulating Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Circulating Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Circulating Biomarker Sales by Country (2017-2022) & (K MT)
Table 103. Middle East and Africa Circulating Biomarker Sales by Country (2023-2028) & (K MT)
Table 104. Middle East and Africa Circulating Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Circulating Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 106. Abbott Laboratories Corporation Information
Table 107. Abbott Laboratories Description and Major Businesses
Table 108. Abbott Laboratories Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. Abbott Laboratories Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbott Laboratories Recent Developments
Table 111. Becton, Dickinson and Company Corporation Information
Table 112. Becton, Dickinson and Company Description and Major Businesses
Table 113. Becton, Dickinson and Company Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Becton, Dickinson and Company Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Becton, Dickinson and Company Recent Developments
Table 116. GE Healthcare Corporation Information
Table 117. GE Healthcare Description and Major Businesses
Table 118. GE Healthcare Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. GE Healthcare Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. GE Healthcare Recent Developments
Table 121. Epigenomics AG Corporation Information
Table 122. Epigenomics AG Description and Major Businesses
Table 123. Epigenomics AG Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Epigenomics AG Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Epigenomics AG Recent Developments
Table 126. Agilent Technologies Corporation Information
Table 127. Agilent Technologies Description and Major Businesses
Table 128. Agilent Technologies Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 129. Agilent Technologies Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Agilent Technologies Recent Developments
Table 131. Biocept Corporation Information
Table 132. Biocept Description and Major Businesses
Table 133. Biocept Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 134. Biocept Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Biocept Recent Developments
Table 136. Affymetrix Corporation Information
Table 137. Affymetrix Description and Major Businesses
Table 138. Affymetrix Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 139. Affymetrix Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Affymetrix Recent Developments
Table 141. Fluxion Biosciences Corporation Information
Table 142. Fluxion Biosciences Description and Major Businesses
Table 143. Fluxion Biosciences Circulating Biomarker Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 144. Fluxion Biosciences Circulating Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Fluxion Biosciences Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Circulating Biomarker Distributors List
Table 149. Circulating Biomarker Customers List
Table 150. Circulating Biomarker Market Trends
Table 151. Circulating Biomarker Market Drivers
Table 152. Circulating Biomarker Market Challenges
Table 153. Circulating Biomarker Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Circulating Biomarker Product Picture
Figure 3. Global Circulating Biomarker Market Share by Type in 2021 & 2028
Figure 3. Circulating DNA Product Picture
Figure 4. Circulating Tumor Cells Product Picture
Figure 5. Other Product Picture
Figure 6. Global Circulating Biomarker Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Medical Research Center
Figure 9. Others
Figure 10. Circulating Biomarker Report Years Considered
Figure 11. Global Circulating Biomarker Sales 2017-2028 (K MT)
Figure 12. Global Circulating Biomarker Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Circulating Biomarker Revenue 2017-2028 (US$ Million)
Figure 14. Global Circulating Biomarker Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Circulating Biomarker Sales Market Share by Region (2017-2022)
Figure 16. Global Circulating Biomarker Sales Market Share by Region (2023-2028)
Figure 17. North America Circulating Biomarker Sales YoY (2017-2028) & (K MT)
Figure 18. North America Circulating Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Circulating Biomarker Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Circulating Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Circulating Biomarker Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Circulating Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Circulating Biomarker Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Circulating Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Circulating Biomarker Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Circulating Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Circulating Biomarker Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Circulating Biomarker in the World: Market Share by Circulating Biomarker Revenue in 2021
Figure 29. Global Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 31. Global Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 32. Global Circulating Biomarker Sales Market Share by Application (2017-2028)
Figure 33. Global Circulating Biomarker Revenue Market Share by Application (2017-2028)
Figure 34. North America Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 35. North America Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 36. North America Circulating Biomarker Sales Market Share by Application (2017-2028)
Figure 37. North America Circulating Biomarker Revenue Market Share by Application (2017-2028)
Figure 38. North America Circulating Biomarker Sales Share by Country (2017-2028)
Figure 39. North America Circulating Biomarker Revenue Share by Country (2017-2028)
Figure 40. U.S. Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 43. Europe Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 44. Europe Circulating Biomarker Sales Market Share by Application (2017-2028)
Figure 45. Europe Circulating Biomarker Revenue Market Share by Application (2017-2028)
Figure 46. Europe Circulating Biomarker Sales Share by Country (2017-2028)
Figure 47. Europe Circulating Biomarker Revenue Share by Country (2017-2028)
Figure 48. Germany Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 49. France Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Circulating Biomarker Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Circulating Biomarker Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Circulating Biomarker Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Circulating Biomarker Revenue Share by Region (2017-2028)
Figure 59. China Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 62. India Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 69. Latin America Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Circulating Biomarker Sales Market Share by Application (2017-2028)
Figure 71. Latin America Circulating Biomarker Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Circulating Biomarker Sales Share by Country (2017-2028)
Figure 73. Latin America Circulating Biomarker Revenue Share by Country (2017-2028)
Figure 74. Mexico Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Circulating Biomarker Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Circulating Biomarker Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Circulating Biomarker Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Circulating Biomarker Sales Market Share by Application (2017-2028)
Figur

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biomarkers Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......

Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......

Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......

Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......

Global Biomarker Technology Market Research Report 2023

Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......

Global Renal Biomarkers Market Research Report 2023

Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......

Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......

Global Cancer Biomarker Market Research Report 2023

Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......

Biomarker Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs